Article Menu
Need Help?
No Article Versions Notes Found
Cite
Boulanger, J.; Boursiquot, J.N.; Cournoyer, G.; Lemieux, J.; Masse, M.S.; Almanric, K.; Guay, M.P.; , the Comité de l’évolution des pratiques en oncologie. Management of Hypersensitivity to Platinum- and Taxane-Based Chemotherapy: cepo Review and Clinical Recommendations. Curr. Oncol. 2014, 21, 630-641. https://doi.org/10.3747/co.21.1966
Boulanger J, Boursiquot JN, Cournoyer G, Lemieux J, Masse MS, Almanric K, Guay MP, the Comité de l’évolution des pratiques en oncologie. Management of Hypersensitivity to Platinum- and Taxane-Based Chemotherapy: cepo Review and Clinical Recommendations. Current Oncology. 2014; 21(4):630-641. https://doi.org/10.3747/co.21.1966
Chicago/Turabian StyleBoulanger, J., J.N. Boursiquot, G. Cournoyer, J. Lemieux, M.S. Masse, K. Almanric, M.P. Guay, and the Comité de l’évolution des pratiques en oncologie. 2014. "Management of Hypersensitivity to Platinum- and Taxane-Based Chemotherapy: cepo Review and Clinical Recommendations" Current Oncology 21, no. 4: 630-641. https://doi.org/10.3747/co.21.1966
APA StyleBoulanger, J., Boursiquot, J. N., Cournoyer, G., Lemieux, J., Masse, M. S., Almanric, K., Guay, M. P., & , the Comité de l’évolution des pratiques en oncologie. (2014). Management of Hypersensitivity to Platinum- and Taxane-Based Chemotherapy: cepo Review and Clinical Recommendations. Current Oncology, 21(4), 630-641. https://doi.org/10.3747/co.21.1966
